Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19 and Behçet's disease: clinical case series.
Espinosa G, Araujo O, Amaro S, Bodro M, Moreno PJ, Moreno R, Ugarte A, Cervera R. Espinosa G, et al. Among authors: bodro m. Ann Rheum Dis. 2021 Mar;80(3):e41. doi: 10.1136/annrheumdis-2020-217778. Epub 2020 Jul 21. Ann Rheum Dis. 2021. PMID: 32719040 No abstract available.
Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis.
Inciarte A, Leal L, González E, León A, Lucero C, Mallolas J, Torres B, Laguno M, Rojas J, Martínez-Rebollar M, González-Cordón A, Cruceta A, Arnaiz JA, Gatell JM, García F; STRIBPEP Study Group. Inciarte A, et al. J Antimicrob Chemother. 2017 Oct 1;72(10):2857-2861. doi: 10.1093/jac/dkx246. J Antimicrob Chemother. 2017. PMID: 29091217 Clinical Trial.
Post-exposure prophylaxis for HIV infection in sexual assault victims.
Inciarte A, Leal L, Masfarre L, Gonzalez E, Diaz-Brito V, Lucero C, Garcia-Pindado J, León A, García F; Sexual Assault Victims Study Group. Inciarte A, et al. HIV Med. 2020 Jan;21(1):43-52. doi: 10.1111/hiv.12797. Epub 2019 Oct 11. HIV Med. 2020. PMID: 31603619 Free PMC article.
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19.
Garcia-Vidal C, Alonso R, Camon AM, Cardozo C, Albiach L, Agüero D, Marcos MA, Ambrosioni J, Bodro M, Chumbita M, de la Mora L, Garcia-Pouton N, Dueñas G, Hernandez-Meneses M, Inciarte A, Cuesta G, Meira F, Morata L, Puerta-Alcalde P, Herrera S, Tuset M, Castro P, Prieto-Gonzalez S, Almuedo-Riera A, Mensa J, Martínez JA, Sanjuan G, Nicolas JM, Del Rio A, Muñoz J, Vila J, Garcia F, Soriano A; Hospital Clinic of Barcelona COVID-19 Research Group. Garcia-Vidal C, et al. Among authors: bodro m. J Antimicrob Chemother. 2021 Nov 12;76(12):3296-3302. doi: 10.1093/jac/dkab321. J Antimicrob Chemother. 2021. PMID: 34473275 Free PMC article.
C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19.
Camon AM, Alonso R, Muñoz FJ, Cardozo C, Bernal-Maurandi J, Albiach L, Agüero D, Marcos MA, Ambrosioni J, Bodro M, Chumbita M, De la Mora L, Garcia-Pouton N, Dueñas G, Hernandez-Meneses M, Inciarte A, Cuesta G, Meira F, Morata L, Puerta-Alcalde P, Rico V, Herrera S, Tuset M, Castro P, Prieto-González S, Almuedo A, Muñoz J, Mensa J, Sanjuan G, Nicolas JM, Del Rio A, Vila J, García F, Martínez JA, Garcia-Vidal C, Soriano A; Hospital Clinic of Barcelona COVID-19 Research Group. Camon AM, et al. Among authors: bodro m. Sci Rep. 2022 Mar 28;12(1):5250. doi: 10.1038/s41598-022-08882-x. Sci Rep. 2022. PMID: 35347166 Free PMC article.
Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study.
Alonso R, Camon AM, Cardozo C, Albiach L, Agüero D, Marcos MA, Ambrosioni J, Bodro M, Chumbita M, de la Mora L, Garcia-Pouton N, Dueñas G, Hernandez-Meneses M, Inciarte A, Cuesta G, Meira F, Morata L, Puerta-Alcalde P, Herrera S, Tuset M, Castro P, Prieto-Gonzalez S, Mensa J, Martínez JA, Sanjuan G, Nicolas JM, Del Rio A, Vila J, Garcia F, Garcia-Vidal C, Soriano A; Hospital Clinic of Barcelona COVID-19 research group. Alonso R, et al. Among authors: bodro m. Infect Dis Ther. 2022 Jun;11(3):1243-1251. doi: 10.1007/s40121-022-00623-x. Epub 2022 Apr 27. Infect Dis Ther. 2022. PMID: 35476212 Free PMC article.
Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients.
Rico-Caballero V, Fernández M, Hurtado JC, Marcos MA, Cardozo C, Albiach L, Agüero D, Ambrosioni J, Bodro M, Chumbita M, De la Mora L, Garcia-Pouton N, Gonzalez-Cordón A, Dueñas G, Hernandez-Meneses M, Inciarte A, Laguno M, Leal L, Macaya I, Martínez MJ, Cuesta G, Meira F, Morata L, Puerta-Alcalde P, Rojas J, Torres B, Castro P, Muñoz J, Mensa J, Martínez JA, Sanjuan G, Vila J, García F, Garcia-Vidal C, Soriano A; COVID-19-Researcher Group. Rico-Caballero V, et al. Among authors: bodro m. Infection. 2022 Oct;50(5):1321-1328. doi: 10.1007/s15010-022-01833-8. Epub 2022 May 13. Infection. 2022. PMID: 35562568 Free PMC article.
Hospital at home treatment with remdesivir for patients with COVID-19: real-life experience.
Pereta I, Morancho A, López N, Ibáñez B, Salas C, Moreno L, Castells E, Barta A, Cubedo M, Coloma E, Cardozo C, García-Pouton N, Ugarte A, Rivero A, Bodro M, Rico V, García L, Altés J, Seijas N, Nicolás D. Pereta I, et al. Among authors: bodro m. Int J Infect Dis. 2023 Feb;127:124-128. doi: 10.1016/j.ijid.2022.12.011. Epub 2022 Dec 13. Int J Infect Dis. 2023. PMID: 36521589 Free PMC article.
143 results